Search Results

Policy

Australian-based regenerative medicine company, Orthocell Ltd, has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market.

January 15, 2021

·

2 min read

Deals

Orthocell announces successful capital raising

Regenerative medicine company Orthocell Limited is pleased to announce that it has received firm commitments for a A$10.6m placement (“Placement”) from professional and sophisticated investors, including existing shareholders providing $10m net of expenses.

May 31, 2019

·

2 min read

Orthocell Granted European Tendon Regeneration Patent

Regenerative medicine company Orthocell is pleased to announce it has been granted a key European Patent.

December 15, 2017

·

3 min read

Orthocell Granted Celgro Patent Protection In Canada

Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.

October 16, 2017

·

3 min read

FDA

Orthocell Receives CE Mark for CelGro

CelGro, for a range of dental bone and soft tissue regeneration procedures, can now be marketed and sold within the European Union (EU).

November 8, 2017

·

4 min read

Business

Orthocell Appoints Surgical Specialties As Exclusive Distributor

October 11, 2017

·

2 min read

Drug Development

CelGro® pre-clinical study validates high quality nerve repair

CelGro® Human Nerve Regeneration Trial Recently Orthocell announced that the first four patients successfully completed participation in the CelGro® nerve regeneration clinical trial.

July 25, 2019

·

6 min read

Orthocell Commences Treatment of its 1,000th Patient

This marks a significant milestone in the Company’s history as it continues to clinically validate its market leading regenerative medicine technologies and drive entry into the US, the world’s largest healthcare market.

December 7, 2017

·

4 min read

Orthocell Receives New Patent For Celgro Platform Technology

September 21, 2017

·

2 min read

Orthocell’s ‘Cell Factory’ Granted Patent in U.S.

January 5, 2016

·

2 min read